Learn about CVE-2023-30995 impacting IBM Aspera Faspex 4.0 to 5.0.5. Discover its high severity rating & follow mitigation steps to address this improper access control vulnerability.
IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 are vulnerable to an improper access control issue that could allow a malicious actor to bypass IP whitelist restrictions using a specially crafted HTTP request.
Understanding CVE-2023-30995
This section will cover the details of CVE-2023-30995, including the vulnerability description, impact, affected systems, and mitigation steps.
What is CVE-2023-30995?
IBM Aspera Faspex versions 4.0 through 4.4.2 and 5.0 through 5.0.5 are susceptible to a security flaw that enables unauthorized users to circumvent IP whitelist restrictions through a carefully constructed HTTP request.
The Impact of CVE-2023-30995
The vulnerability poses a high severity risk with a CVSS v3.1 base score of 7.5. Attackers could exploit this issue to compromise the integrity of the system without requiring user interaction.
Technical Details of CVE-2023-30995
Below are the technical details related to CVE-2023-30995:
Vulnerability Description
IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist restrictions using a specially crafted HTTP request.
Affected Systems and Versions
Exploitation Mechanism
The vulnerability could be exploited by sending a specifically designed HTTP request to bypass IP whitelist restrictions, granting unauthorized access to the system.
Mitigation and Prevention
To address CVE-2023-30995, consider the following mitigation strategies:
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates
Ensure timely installation of security patches and software updates to prevent exploitation of known vulnerabilities.